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Interleukin-17 (IL-17) is a proinflammatory cytokine produced
mainly by activated CD4+ and CD8+ T cells, while its specific receptor
is ubiquitously distributed. The inflammatory capacity of IL-17 is based
on its ability to stimulate a wide range of stromal cells to produce and
release a number of proinflammatory mediators, some with a known
impact on hematopoiesis, particularly granulopoiesis. Recent data
indicate a role for IL-17 in the pathogenesis of several inflammatory
diseases, transplant rejection and tumor growth. The purpose of this
study was to determine functional responses, including the respiratory
burst, nitric oxide (NO) production, adhesiveness and metabolical
activity/viability of human peripheral blood leukocytes (total white blood
cells, mononuclear cells and granulocytes) from healthy donors in the
presence of recombinant human (rh)IL-17. The obtained results
showed that rhIL-17 did not induce significant changes in the
respiratory burst, NO production, and metabolical activity of each
peripheral blood cell fraction the tested, while a slight increase in
phorbol-12-myristate-13-acetate (PMA) stimulated adhesiveness of
granulocytes and mononuclear cells was noted. The absence of
significant changes in tested functional activities of various peripheral
blood cells suggests that IL-17 does not express its proinflammatory
ability in steady-state, since the requirement for its action really does not
exist.
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INTRODUCTION
IL-17 is a newly described cytokine, first identified as the human homolog of
cytotoxic T lymphocyte-associated antigen 8, CTLA-8 (Rouvier et al., 1993). Since
CTLA-8 displayed some of the features of cytokine genes, such as the predicted
hydrophobic NH2-terminal sequence which could correspond to a signal peptide,
and the presence of a 3’ untranslated region of AU rich repeats associated with
mRNA instability, it was subsequently renamed as IL-17. IL-17 is recognized as the
prototype member of an emerging cytokine family, comprising least six members
(IL-17 A, B, C, D, E, F), which together with the cognate receptors represent a
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unique signaling system that appears to be highly conserved across vertebrate
evolution (Aggarwal and Gurney, 2002). Human IL-17 is a 20-30 kDa
homodimeric, variably glycosylated polypeptide mainly produced by activated
CD4+ and CD8+ T cells, mostly of the memory CD45RO+subset (Fossiez et al.,
1998). In contrast to its apparently restricted expression, the receptor for IL-17
shows an almost ubiquitous cellular distribution (Yao et al., 1997).
IL-17 exhibits pleiotropic biological activities, attributed mostly to its ability to
stimulate production of numerous biologically active molecules by a variety of
cells, among which are hematopoietic and proinflammatory cytokines (Fossiez et
al., 1996). Accumulating evidence has shown that IL-17 is an important mediator
of inflammation, especially in neutrophil-dominated responses to bacterial
challenge (Witowski et al., 2004). Nevertheless, even the first data indicated that
IL-17 provides a link between T-cell immune responses and hematopoietic
system. In their seminal paper Fossiez et al. (1996) demonstrated that IL-17
sustained the proliferation of human CD34+ hematopoietic progenitors and their
maturation into neutrophils in vitro, only in the presence of the fibroblast feeder
layer. In addition, IL-17 overexpression in vivo induced granulopoiesis in mice
(Schwarzenberger et al., 1998).
Recent data support a role for IL-17 in the pathogenesis of several
inflammatory diseases, transplant rejection and tumor growth (Schwarzenberger
and Kolls, 2002). Elevated levels of IL-17 have been found in the synovial fluid from
rheumatoid arthritis patients, in sputum and bronchoalveolar fluid in asthma as
well as in colorectal tissues and serum of subjects with active inflammatory bowel
disease (Kotake et al., 1999; Molet et al., 2001; Fujino et al., 2003). Its mRNA
expression was increased in mononuclear cells in multiple sclerosis
(Matusevicius et al., 1999) and in T lymphocytes isolated from psoriatic and atopic
contact dermatitis lesions (Albanesi et al., 1999; Teunissen et al., 1998). It has
been postulated that its contribution to these inflammatory processes is exerted
by stimulation of a wide range of stromal cells to produce and release a number of
proinflammatory mediators (Witowski et al., 2004; Aggarwal and Gurney, 2002),
among which are those that attract leukocytes, predominantly neutrophils, to the
site of inflammation (IL-8, GRO, GCP-2, MCP-1), activate their effector functions
(IL-1, TNF) or stimulate granulopoiesis in bone marrow (IL-6, G-CSF, GM-CSF).
It is well known that upon stimulation the functional responses of activated
leukocytes differ depending on the leukocyte cell subset and in addition to
production of cytokines and other inflammatory mediators, may include shape
change, adhesion, aggregation, chemotaxis, degranulation, phagocytosis and
respiratory burst. The aim of this study was to analyze the effects of IL-17 on
human peripheral blood leukocytes obtained from healthy volunteers. The
respiratory burst, nitric oxide (NO) production, adhesiveness and metabolical
activity/viability of total white blood cells (WBC), as well as granulocytes and
mononuclear cell populations were investigated.
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MATERIAL AND METHODS
Separation of peripheral blood cells
Peripheral blood was obtained from healthy persons. Separation of WBC
was performed by mixing 6% HES (Hydroxyethylstarke, Plasmasteril, Frasenius,
Hamburg, Germany) with heparinized venous peripheral blood at 1:7 ratio,
followed by centrifugation at 2700rpm for 15 min. Peripheral blood mononuclear
cells and granulocytes were separated using an isotonic discontinuous Percoll
gradient (Amersham Pharmacia Biotech, Uppsala, Sweden). Heparinized
peripheral blood was diluted with 0.15 M NaCl at the ratio of 1:1 and over layered
on Percoll solutions of specific gravity 1.09 and 1.07 g/ml. After centrifugation at
1300 rpm for 30 min at room temperature, mononuclear cell and granulocyte
layers were recovered and subsequently removed. The remaining erythrocytes in
the isolated cell fractions were lysed using isotonic NH4Cl solution (155 mM
NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4). Separated WBC, mononuclear
cells and granulocytes were washed twice in Dulbecco’s modified Eagle’s
medium (DMEM, Sigma Chemicals Co., St. Louis, Mo., USA) and suspended in
DMEM supplemented with 10% fetal calf serum (FCS, Sigma Chemicals Co., St.
Louis, Mo., USA) to a concentration of 5x106 cells/ml. The purity of mononuclear
and granulocyte cell fractions was more than 98%, as determined by May-
Grünwald-Giemsa staining.
NBT reduction assay
The activation of each isolated peripheral blood cell fraction was evaluated
by cytochemical assay for the respiratory burst (Monboisse et al., 1991),
measured by the intracellular reduction of nitroblue tetrazolium salt (NBT, Merck,
Germany). Increasing concentrations of rhIL-17 (0, 50, 100, 500 ng/ml) (R&D
Systems, Minneapolis, MN, USA) and NBT (10 l, 5 mg/ml) were added to each
cell suspension tested (5x105 cells/well, 100 l), plated in 96-well plates and
incubated for 30 min. For the measurement of spontaneous or stimulated NBT
reduction, cells were incubated in medium only or in the presence of 50 ng/ml
PMA (Sigma Chemicals Co., St. Louis, Mo., USA), respectively. Formazan
produced by the cells was extracted overnight in 10% SDS-0.1N HCl at 37oC and
was measured spectrophotometrically at 540 nm in an ELISA 96-well plate reader
(Labsystems Multiskan PLUS, Finland).
Measurement of nitric oxide production
WBC, mononuclear cells or granulocytes were plated, in 96-well plates
(5x105 cells/well, 100 l) along with increasing concentrations of rhIL-17 (0, 50,
100, 500 ng/ml) and cultivated for 24h in the presence or absence of 1000 ng/ml
LPS (lipopolysaccharide from E. coli, serotype 055: B5 strain; Sigma Chemicals
Co., St. Louis, Mo., USA). Production of nitric oxide, quantified by the
accumulation of nitrite in the 24h culture medium, was measured
spectrophotometrically using the Griess reaction with sodium nitrite as standard
(Green et al., 1982). Briefly, 50 l of culture supernatants were mixed with equal
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volumes of 1% sulfanilamide (Sigma Chemicals Co., St. Louis, Mo., USA) in 5%
H3PO4 and 0.1% N-1-naphthylethylene diamine dihydrochloride (Sigma
Chemicals Co., St. Louis, Mo., USA) in distilled water and after 10 min at room
temperature, the absorbance at 540 nm was measured.
Measurement of adhesion
Adhesion of peripheral blood cells to plastic was assessed using a modified
assay initially described by Oez et al. (1990). Peripheral blood cells were plated
(5x105 cells/well, 100 l) in 96-well plates in the presence of rhIL-17 (0, 50, 100,
500 ng/ml) and incubated for 60 min. For the measurement of spontaneous or
stimulated adhesion, cells were incubated in medium only (spontaneous
adhesion), or in the presence of 50 ng/ml PMA (stimulated adhesion). After this
incubation, non-adherent cells were carefully removed by sequentially adding
and aspirating the saline three times. Cells adhering to the plastic surface were
fixed with methanol for 8 min and then stained with 0.1% crystal violet for 10 min at
room temperature. The plates were washed three times in running water and left
to air dry. The dye was dissolved in 200 l of 33% acetic acid and the absorbance
was measured at 540 nm in an ELISA 96-well plate reader.
MTT assay
Metabolic activity/viability of the peripheral blood cells was analyzed by a
quantitative colorimetric assay in which 3-(4,5-dimethyl-thiazol-2yl)-2,5 diphenyl-
tetrazolium bromide (MTT, ICN Biomedicals, Ohio, USA) was metabolically
reduced to the colored end product, formazan (Mosmann et al., 1983). The MTT
assay was conducted with freshly isolated cells in the presence of increasing
concentrations of rhIL-17 (0, 50, 100, 500 ng/ml). WBC, mononuclear cells or
granulocytes were added to the wells (5x105 cells/well, 100 l) of 96-well plates.
Immediately, MTT (10 l, 5 mg/ml) was added and the cultures were incubated for
3h at 37oC in a humidified atmosphere. Formazan produced by the cells was
dissolved during overnight incubation in SDS-HCl (10%SDS-0.1N HCl) and
subsequently its absorbance was measured at 540 nm in an ELISA 96-well plate
reader.
Data display and statistical analysis
Each test for every isolated peripheral blood cell fraction was performed at
least three times. Statistical analysis was performed by Student's t-test, using the
Origin PC Program with the actual numbers of each investigated parameter. A p
value less than 0.05 was considered significant.
RESULTS
Effect of IL-17 on NBT reduction by peripheral blood cells
The respiratory burst activity of peripheral blood cells upon stimulation with
rhIL-17 (0, 50, 100, 500 ng/ml) was evaluated by a cytochemical test for respiratory
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burst based upon the capacity of cells to reduce NBT (Monboisse et al., 1991).
NBT reduction occurs by a chemical reaction between the dye and the superoxide
anion (O2–) generated by the activated respiratory burst NADPH oxidase. No
significant changes in spontaneous NBT reduction by WBC, peripheral
granulocytes and mononuclear cells were detected. in the presence of increasing
concentrations of rhIL-17. However, the responses to IL-17 given by mononuclear
cells and granulocytes were up to 20% higher in comparison to the spontaneous
NBT reduction observed in medium only. PMA-stimulated NBT reduction by all
tested peripheral blood cells was not affected significanlty in the presence of rhIL-
17 (Figure 1).
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Figure 1. The effect of rhIL-17 on NBT reduction by human peripheral blood cells. WBC (A),
mononuclear cells (B) and granulocytes (C) were incubated with increasing con-
centrations of rhIL-17 in the absence or presence of PMA. NBT reduction is ex-
pressed as absorbance at 540 nm. The results are presented as the mean ± SE




Effect of IL-17 on NO production by peripheral blood cells
It is well known that inflammatory cytokines can stimulate peripheral blood
leukocytes, predominantly mononuclear phagocytes and neutrophils, to produce
NO. In order to evaluate NO production by human peripheral blood cells in the
presence of rhIL-17, nitrite accumulation in 24h culture supernatants of WBC,
granulocytes or mononuclear cells was determined. As presented in Figure 2, IL-
17 did not influence spontaneous or LPS-stimulated NO production by WBC.
Moreover, rhIL-17 did not induce changes in spontaneous and LPS-stimulated NO
production by peripheral blood mononuclear cells and granulocytes either (data
not shown).
Effect of IL-17 on peripheral blood cell adhesion to plastic
Plastic microtitre plates are widely used in the assessment of leukocyte
function since the plastic surface behaves physiologically with respect to
leukocyte adhesion (Forsyth and Levinsky, 1989; Oez et al., 1990). The adhesion
to plastic of WBC, as well as mononuclear cells and granulocytes was determined
in the presence of increasing concentrations of rhIL-17. No rhIL-17 concentration
used induced changes in spontaneous adhesion of WBC, mononuclear cells or
granulocytes (Figure 3). A slight, but statistically insignificant increase in PMA-
stimulated granulocyte adhesion was detected in the presence of rhIL-17 at 100
and 500 ng/ml (approximately 27% of the response determined with PMA alone).
A similar increase in adhesiveness was observed in the population of
mononuclear cells, but only at the highest concentration of rhIL-17 used (500
ng/ml). However, in WBC cultures no effect of rhIL-17 on PMA- stimulated
adhesion was noted.
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Figure 2. The effect of rhIL-17 on NO production by human peripheral blood cells. WBC
were incubated with increasing concentrations of rhIL-17 in the absence or pres-
ence of LPS and nitrite accumulation in cell culture supernatants was deter-
mined after 24h. NO production is expressed as nitrite concentration (M). The
results are presented as the mean ± SE of three experiments each performed in
triplicate.
Effect of IL-17 on MTT reduction by peripheral blood cells
MTT is metabolically reduced exclusively by living cells and therefore it is
recommended as a quantitative colorimetric assay for the measurement of
cellular proliferation, viability and cytotoxicity (Mosmann et al., 1983). To estimate
if rhIL-17 affected the metabolic activity/viability of peripheral white blood cells, we
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Figure 3. Figure 3. The effect of rhIL-17 on human peripheral blood cell adhesion to plastic.
WBC (A), mononuclear cells (B) and granulocytes (C) were cultured with increas-
ing concentrations of rhIL-17 in the absence or presence of PMA and adherence
to plastic was measured after 60 min incubation at 37oC. Adhesion is expressed
as absorbance at 540 nm. The results are presented as the mean ± SE of tripli-




conducted the MTT assay with freshly isolated total WBC, granulocytes or
mononuclear cells in the presence of increasing concentrations of rhIL-17, since
only metabolically viable cells reduce soluble tetrazolim salt-MTT to insoluble
formazan (Jabbar et al., 1989). None of the rhIL-17 concentrations tested induced
any significant changes in the levels of MTT reduction by either examined
peripheral blood cell fraction (Figure 4). The estimated levels of MTT reduction in
the presence of rhIL-17 were no more than 10% different from the response
observed with medium alone.
DISCUSSION
Peripheral blood leukocytes circulate in the vasculature in a passive,
quiescent state. In the course of inflammation they are recruited to the site of
inflammation, where they become activated by cytokines and inflammatory
mediators to express their effector functions. IL-17 has been classified as a
proinflammatory cytokine because of its ability to induce expression of many
mediators of inflammation, but the data concerning its activity on peripheral blood
leukocytes are limited. In this study we have examined if the proinflammatory
activity of IL-17 can be extended to the functional activation of peripheral blood
leukocytes, since this property of IL-17 may be of importance in the pathogenesis
of chronic inflammatory diseases.
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Figure 4. Figure 4. The effect of rhIL-17 on MTT reduction by human peripheral blood cells.
Freshly isolated human peripheral WBC (), mononuclear cells () and granulo-
cytes () were exposed to increasing concentrations of rhIL-17 and MTT reduc-
tion was measured after 3h incubation at 37oC. MTT reduction is expressed as
absorbance at 540 nm. The results are presented as the mean ± SE of triplicate
samples from one experiment representative of three.
Macrophages, neutrophils and other phagocytic cells are key components
of the antimicrobial and tumoricidal immune responses, due to their capability to
generate large amounts of highly toxic molecules - reactive oxygen (ROIs) and
nitrogen intermediates (RNIs). The production of the oxygen radical, superoxide
(O2–), is mediated by activation of respiratory burst NADPH oxidase. It is known
that in resting cells NADPH oxidase is dormant and is activated upon stimulation
by different mechanisms depending on the agonist used, either various cytokines
or different microbial products, such as LPS, PMA, fMLP (N-formyl-methionyl-
leucyl-phenylalanine). Proinflammatory cytokines, IL-1/, TNF, GM-CSF, IL-6
and IL-8, have been shown to interact with polymorphonuclear neutrophils (PMN)
by stimulating the oxidative burst and/or exerting a priming effect, i.e. enhancing
the PMN response to a secondary applied stimulus (Elbim et al., 1994). However,
in our study IL-17 did not provoke any significant changes in respiratory burst
activity of the total peripheral blood leukocytes, or granulocytes or mononuclear
cells, either at the level of spontaneous or PMA-stimulated NBT reduction.
The production of NO, by inducible NO synthase (iNOS) enzyme, is also
regulated by various inflammatory cytokines (TNF, IFN, IL-18, IL-1/) and
bacterial products (e.g. LPS) at transcriptional and posttranscriptional levels
(Bogdan et al., 2000). IL-17 was previously reported to induce NO production in
various cells, such as human chondrocytes, mouse osteoblasts, rodent
astrocytes and endothelial cells (Miljkovi} and Trajkovi}, 2004). However, in our
experiments no changes were detected in the basal levels of NO production by
total WBC, granulocytes or mononuclear cells after 24h incubation with rhIL-17.
This is in agreement with the data demonstrating that human peripheral blood
mononuclear phagocytes, neutrophils and T lymphocytes, produce no or little NO
after various treatments in vitro (Weinberg et al., 1995; Webb et al., 2000; Arcos et
al., 2003). Moreover, it was reported that IL-17 was unable to stimulate significant
NO release in cultured human monocytes or rodent macrophages (Jovanovic et
al., 1998; Trajkovi} et al., 2001).
Circulating peripheral blood leukocytes are known to become more
adhesive upon stimulation at the sites of inflammation. The adhesiveness of
leukocytes to various matrices is used as an in vitro correlate of leukocyte
adherence to endothelium or connective tissue (Oez et al., 1990). Numerous
leukocyte functions dependent on adhesion are mediated by 2 intergrins
(CD11/CD18), normally expressed on the cell surface, although the relative
abundance and the mode of CD11/CD18 avidity varies depending on the cell type
and the state of cell activation and differentiation (Arnaout, 1990). The critical
importance of the CD11/CD18 complex was also demonstrated for leukocyte
adhesion to plastic (Schleiffenbaum et al., 1989). IL-17 in our experiments did not
induce significant changes in the spontaneous adhesion of peripheral
mononuclear cells and granulocytes, but a slight stimulation of adhesiveness was
observed during the simultaneous presence of IL-17 and PMA. This finding
pointed to a possible contribution of IL-17 in the priming of these cells. Previous
data showed that various inflammatory mediators, such as TNF, IL-8, GM-CSF
and C5a prime neutrophils to respond more effectively to a subsequent
stimulation (Daniels et al., 1994; Hallet and Loyds, 1995). In this regard, it is
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possible that IL-17 can also prime peripheral blood granulocytes and
mononuclear cells, probably by inducing changes at the level of signal
transduction, enabling them to respond to PMA, as a secondary stimulus, with
stronger adhesiveness.
The level of MTT reduction directly correlates with the number of
metabolically active cells in the culture (Mosmann, 1983; Carmichael et al., 1987).
Cellular bioreduction of MTT is associated with the activity of NADPH- and NADH-
dependent enzymes of the endoplasmatic reticulum, as well as mitochondrial
succinate dehydrogenase. The production of reduced pyridine nucleotides
during glucose metabolism was reported to be rate limiting for cellular MTT
reduction (Berridge et al., 1996). Also, the critical role of glucose-6-phosphate
dehydrogenase (G6PDH) activity, the rate-limiting enzyme of the glycolytic and
pentose phosphate pathway, was emphasized in the regulation of cell
death/survival (Tian et al., 1999). In this regard changes in MTT reduction were
recommended as an assay for the assessment of the overall functional state of
human polymorphonuclear leukocytes. According to our results obtained from
the MTT assay it seems that rhIL-17 does not affect the overall metabolical activity
of WBC, peripheral blood granulocytes and mononuclear cells from healthy
persons.
The presented results demonstrate that IL-17 induced no or little changes in
various functional activities of total peripheral blood leukocytes, granulocytes and
mononuclear cells from normal subjects, suggesting that IL-17 does not express
any proinflammatory ability in steady-state, since the requirement for its action
really does not exist. This is consistent with data showing that IL-17 had no effect
on the secretion of proinflammatory cytokines by blood monocytes (Fossiez et al.,
1996), but stimulated the production and expression of IL-1 and TNF only by
activated macrophages (Jovanovic et al., 1998). In addition, this finding is in
agreement with other studies reporting that leukocyte responsiveness to
cytokines requires additional stimulation, such as adherence or combined action
with other cytokines (Jovanovic et al.,1998; Nathan et al., 1989). This also may be
a reason why circulating leukocytes are not routinely activated by the low level of
circulating cytokines. Moreover, numerous reports have documented that IL-17
alone induce weak responses in various stromal cells, but emphasized its
synergistic action with other proinflammatory cytokines, implying a possible role
as a “fine-tuning” element in the complex cytokine network (Katz et al., 2001;
LeGrand et al., 2001; Chabaud et al., 2001). In our previous study we
demonstrated that the influence of IL-17 on hematopoietic progenitor cell growth
and cytokine release was dependent on the physiological/pathological status of
the organism and that IL-17 exerted a more prominent effect especially on
cytokine secretion in post-irradiated murine bone marrow cells (Jov~i} et al,
2001). Increased levels of IL-17 have been associated with some chronic
inflammatory conditions, such as rheumatoid arthritis, (RA), in which circulating
leukocytes exhibit several features indicative of partial activation (Edwards and
Hallett, 1997). Since prior in vivo priming could alter subsequent leukocyte
functions, our future studies will consider if IL-17 can modulate the functional
258 Acta Veterinaria (Beograd), Vol. 54. No. 4, 249-261, 2004.
Vla{ki Marija et al. Effects of IL-17 on functional activity
of peripheral blood cells
activity of peripheral blood leukocytes obtained from patients with RA or other
chronic inflammatory diseases.
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EFEKTI IL-17 NA FUNKCIONALNU AKTIVNOST ]ELIJA PERIFERNE KRVI
VLA[KI MARIJA, KRSTI] ALEKSANDRA, JOV^I] GORDANA, BUGARSKI DIANA,
PETAKOV MARIJANA, STOJANOVI] NEVENKA i MILENKOVI] P
SADR@AJ
Interleukin 17 (IL-17) je proinflamatorni citokin koga produkuju aktivirane
CD4+ i CD8+ T }elije, dok je njegov receptor ubikvitarno distribuiran. Inflamatorni
kapacitet IL-17 se zasniva na njegovoj sposobnosti da stimuli{e {irok spektar
stromalnih }elija da produkuju i osloba|aju razli~ite proinflamatorne medijatore,
me|u kojima neki imaju efekte na hematopoezu, posebno granulopoezu.
Dosada{nji podaci ukazuju na ulogu IL-17 u patogenezi razli~itih inflamatornih
bolesti, odbacivanju transplanta i razvoju tumora. Cilj ovog rada je bio da se
odrede funkcionalni odgovori, uklju~uju}i respiratorni prasak, produkciju azot
monoksida (NO), adhezivnost i metaboli~ku aktivnost/vijabilnost razli~itih }elija
periferne krvi (ukupnih leukocita, mononuklearnih }elija i granulocita) zdravih
donora, u prisustvu IL-17. Dobijeni rezultati su ukazali da IL-17 ne dovodi do
zna~ajnih promena respiratornog praska, produkcije NO i metaboli~ke aktivnosti
}elija periferne krvi, ali da uzrokuje blago pove}anje forbol-12-miristat-13-acetat
(PMA) stimulisane adhezivnosti granulocita i mononuklearnih }elija. Odsustvo
zna~ajnih promena u ispitivanim funkcionalnim aktivnostima razli~itih }elija
periferne krvi, ukazuje da IL-17 ne eksprimira proinflamatorno dejstvo kod zdravih
osoba, jer najverovatnije i ne postoji potreba za njegovim delovanjem.
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